Harmony Biosciences Holdings Inc. (HRMY) Social Stream
HARMONY BIOSCIENCES HOLDINGS INC (HRMY) Price Targets From Analysts
Use the tables below to see what analysts covering HARMONY BIOSCIENCES HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-28 | 4 | $58 | $54 | $56.5 | $49.66 | 13.77% |
| 2022-02-01 | 5 | $60 | $55 | $57.4 | $49.66 | 15.59% |
| 2022-03-01 | 5 | $58 | $55 | $56.8 | $49.66 | 14.38% |
| 2022-04-10 | 5 | $59 | $55 | $57.2 | $49.66 | 15.18% |
| 2022-05-04 | 6 | $63 | $55 | $58.166 | $49.66 | 17.13% |
| 2022-05-10 | 6 | $63 | $55 | $57.833 | $49.66 | 16.46% |
| 2022-07-14 | 8 | $64 | $55 | $59.125 | $49.66 | 19.06% |
| 2022-08-03 | 8 | $64 | $55 | $59.125 | $49.66 | 19.06% |
| 2022-08-04 | 7 | $69 | $55 | $61.285 | $49.66 | 23.41% |
| 2022-10-13 | 7 | $69 | $55 | $61.285 | $49.66 | 23.41% |
| 2022-10-19 | 7 | $69 | $55 | $61.857 | $49.66 | 24.56% |
| 2022-10-21 | 7 | $69 | $51 | $61.285 | $49.66 | 23.41% |
| 2022-11-03 | 8 | $71 | $51 | $63.5 | $49.66 | 27.87% |
| 2022-11-30 | 8 | $71 | $51 | $64.75 | $49.66 | 30.39% |
| 2023-01-17 | 8 | $71 | $51 | $65.75 | $49.66 | 32.4% |
The Trend in the Analyst Price Target
HRMY's average price target has moved up $14.42 over the prior 17 months.
Over the past 50 weeks, HRMY's average upside potential has been 28.76%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-14 | 8 | 64 | 55 | 59.125 | 52.97 | 11.62% |
| 2022-08-04 | 8 | 69 | 55 | 61.285 | 52.36 | 17.05% |
| 2022-10-14 | 7 | 69 | 55 | 61.857 | 51.07 | 21.12% |
| 2022-11-08 | 8 | 71 | 51 | 64.750 | 58.65 | 10.4% |
| 2023-01-17 | 8 | 71 | 51 | 65.750 | 49.04 | 34.07% |
HRMY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 5 | 2 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
HRMY's average broker recommendation rating worsened by 0.1 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, HARMONY BIOSCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -225.81% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, HARMONY BIOSCIENCES HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 332.39% of them.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1354.44% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, HARMONY BIOSCIENCES HOLDINGS INC's number of analysts covering the stock is higher than 762.08% of them.
In the Pharmaceutical Products industry, PRLD, PMVP, and ME are the three stocks most similar to HARMONY BIOSCIENCES HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is HRMY a Buy, Hold or Sell? See the POWR Ratings now!